BridgeMD
New treatment option for Primary; Coxarthrosis
Official title Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis
ClinicalTrials.gov ID: NCT06258369
What this study is testing
- What it's testing
- The study consists to evaluate the impact of prosthetic surgery (PTH and RTH) on kinematic and dynamic parameters (joint torques) of the lower limbs during gait initiation in patients with primary coxarthrosis. Patients included in the study will undergo a three-dimensional gait analysis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Men or women aged 18 and over
- With primary coxarthrosis (any stage)
- Consulting in the orthopedic departments of participating centers in anticipation of hip surgery (PTH/RTH), or for advice only.
- Written consent signed by the patient
- Affiliation with a social security scheme
You likely can't join if
- Disabling orthopaedic conditions: Symptomatic contralateral hip/knee disease Symptomatic gonarthrosis or homolateral total knee prosthesis History of...
- Pregnant or breast-feeding
- Adults under guardianship, curatorship or safeguard of justice
- Cognitive impairment making it impossible to understand the protocol
- Approach other than Moore posterolateral (for PTH and RTH groups)
The study team makes the final eligibility decision.
Where it's taking place
- Lille, France
- Lomme, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lille, France; Lomme, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.